VRS.L

Versarien Plc
Versarien PLC - Disposal of AAC Cyroma Limited
30th September 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 1116G
Versarien PLC
30 September 2024
 

30 September 2024

 

Versarien plc

 

("Versarien" or the "Company" or the "Group")

 

Disposal of AAC Cyroma Limited

 

Versarien plc (AIM: VRS), the advanced materials engineering group, announces that, in line with the Company's stated strategy, it has completed a binding agreement for the sale of the Company's wholly owned subsidiary, AAC Cyroma Limited ("AAC Cyroma"), to Harper Bennett Limited for a total consideration of £550,000, subject to any adjustments arising from completion accounts.

 

The consideration of £550,000 is payable in cash, in 16 equal quarterly instalments of £34,375, commencing three months from completion.  Versarien will retain a charge over the assets of AAC Cyroma and Harper Bennett Limited to cover any outstanding consideration payable.

 

AAC Cyroma is a specialist plastics manufacturing business serving a range of sectors including automotive and fast-moving consumer goods.  In the financial year ended 30 September 2023 AAC Cyroma incurred a loss of £146,350 and had net assets at 30 September 2023 of £411,142.  The disposal of AAC Cyroma is in line with the Company's strategy to focus on its core graphene technology and divesting of its mature businesses.  The proceeds of the disposal will be used for the Company's general corporate and working capital purposes.

 

Stephen Hodge, Chief Executive Officer of Versarien, commented: "The sale of AAC Cyroma is a pivotal step in our turnaround strategy, allowing the Company to continue to focus on maximising the potential from graphene and advanced engineering technologies, and take a manufacturing-light approach.  In our core business the pipeline of opportunities and partnerships continues to improve and I believe that Versarien is increasingly well positioned for sustained growth and industry leadership."

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

c/o IFC



SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 



IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien:

 

The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a manufacturing-light and licensing model.

 

For further information please see: http://www.versarien.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSEMFWWELSEFU]]>
TwitterFacebookLinkedIn